KPP Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
KPP Advisory Services's BMY Position: Q2 2026 in Review
KPP Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q2 2026, selling an estimated $7K and leaving 4,213 shares worth $243K. The position accounts for 0.03% of the portfolio, ranked #331.
KPP Advisory Services first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $582K in Q3 2023. 829 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- KPP Advisory Services held 4,213 shares of Bristol-Myers Squibb worth $243K as of Q2 2026.
- KPP Advisory Services sold 122 Bristol-Myers Squibb shares in Q2 2026, an estimated $7K.
- Bristol-Myers Squibb made up 0.03% of KPP Advisory Services's portfolio in Q2 2026, its #331 holding.
- KPP Advisory Services first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
- KPP Advisory Services's Bristol-Myers Squibb position peaked at $582K in Q3 2023.
- 829 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on KPP Advisory Services's 13F filing for Q2 2026, filed 24 Jul 2026.